Dr. Webster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 N. Broadway
Baltimore, MD 21231Phone+1 410-955-8964Fax+1 410-614-7279- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Medical Oncology, 2017- Johns Hopkins UniversityResidency, Internal Medicine, 2011 - 2013
Stanford University School of MedicineClass of 2011
Certifications & Licensure
VA State Medical License 2021 - 2026
MD State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance Start of enrollment: 2017 Sep 05
Roles: Contact, Principal Investigator
- Post-transplant Flotetuzumab for AML Start of enrollment: 2022 Oct 20
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death.Jia Jia, Wenbo Ji, Antoine N Saliba, Clifford M Csizmar, Kaiqin Ye, Lei Hu, Kevin L Peterson, Paula A Schneider, X Wei Meng, Annapoorna Venkatachalam, Mrinal M Patnaik...> ;Cell Death and Differentiation. 2024 Mar 27
- Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplan...Kayser, S., Sartor, C., Giglio, F., Bruno, A., Webster, J., Chiusolo, P., Saraceni, F., Guerzoni, S., Pochintesta, L., Borlenghi, E., Marconi, G., Zacheo, I., Cerrano,...> ;Haematologica. 2023 Dec 7
- 1 citationsA phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia.Aref Al-Kali, Ibrahim Aldoss, Pamela J Atherton, Carrie A Strand, Bijal Shah, Jonathan Webster, Bhavana Bhatnagar, Karen S Flatten, Kevin L Peterson, Paula A Schneider...> ;Cancer Medicine. 2023 Dec 1
- Join now to see all
Abstracts/Posters
- Final Clinical Results of a Phase II Study of High Dose Cytarabine Followed By Pembrolizumab in Relapsed/Refractory AMLJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Coagulopathy, Hypoxemia, and Mortality Outcomes in Newly Diagnosed Acute Myeloid Leukemia with Hyperleukocytosis Treated with Large Volume LeukapheresisJonathan Webster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
- Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF RegistryJune 1st, 2019
Hospital Affiliations
Johns Hopkins HospitalBaltimore, Maryland
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
